Revelation Biosciences

Menlo Park, United States

Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.

$11.2M raised

Jan 2026

Post-IPO Equity

Biotechnology Health Care Medical Therapeutics

Top Investors

National Securities Corporation Global Health Funds

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Revelation Biosciences

How much funding has Revelation Biosciences raised?

Revelation Biosciences has raised $11.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.

Who are Revelation Biosciences's investors?

Revelation Biosciences's investors include National Securities Corporation, Global Health Funds.

Where is Revelation Biosciences headquartered?

Revelation Biosciences is headquartered in Menlo Park, United States.

What does Revelation Biosciences do?

Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.

What stage is Revelation Biosciences at?

Revelation Biosciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 23, 2026.

MLA

"Revelation Biosciences — Funding & Investors." VCBacked, January 23, 2026, https://www.vcbacked.co/company/revelation-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2026). Revelation Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/revelation-biosciences

Wikipedia (cite web)

{{cite web |title=Revelation Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/revelation-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 23, 2026.